Group items tagged

The market for varicose vein treatment is highly fragmented; the increasing prevalence of varicose veins and growing geriatric population are among the primary factors driving the market growth. However, the high cost of treatment procedure and lack of skilled professionals are hampering the growth of the market. The treatment cost for varicose veins is high and the reimbursement scenario is very inconsistent. In 2018, 3 out of 10 individuals were affected by varicose veins with health expenses being more than $10 billion. These costs have increased annually due to a sedentary lifestyle, growing elderly population, and the prevalence of obesity.